Tesamorelin
Tesamorelin
Tesamorelin (pronunciation: te-sa-MOR-e-lin) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy.
Etymology
The term "Tesamorelin" is derived from its chemical structure. It is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Usage
Tesamorelin is used to reduce excess fat around the stomach and other parts of the body in people with HIV and lipodystrophy. Lipodystrophy is a condition that causes changes in the distribution of body fat. Tesamorelin works by stimulating the pituitary gland to increase the production of certain natural substances including growth hormone.
Related Terms
- Growth hormone: A hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals.
- Lipodystrophy: A disorder of adipose tissue characterized by a selective loss of body fat.
- HIV: Human Immunodeficiency Virus, a virus that attacks the body's immune system.
Side Effects
Common side effects of Tesamorelin include joint pain, skin rash, and muscle soreness. In some cases, it may cause more serious side effects such as changes in blood sugar levels, increased heart rate, and allergic reactions.
Precautions
Before using Tesamorelin, patients should inform their healthcare provider if they have any allergies, are pregnant or planning to become pregnant, or are breastfeeding. It is also important to inform the healthcare provider about any other medications being taken, as Tesamorelin may interact with them.
External links
- Medical encyclopedia article on Tesamorelin
- Wikipedia's article - Tesamorelin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski